U.S. flag

An official website of the United States government

NM_000152.5(GAA):c.309C>G (p.Cys103Trp) AND Glycogen storage disease, type II

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 29, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001896806.4

Allele description [Variation Report for NM_000152.5(GAA):c.309C>G (p.Cys103Trp)]

NM_000152.5(GAA):c.309C>G (p.Cys103Trp)

Gene:
GAA:alpha glucosidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_000152.5(GAA):c.309C>G (p.Cys103Trp)
HGVS:
  • NC_000017.11:g.80104895C>G
  • NG_009822.1:g.8340C>G
  • NM_000152.5:c.309C>GMANE SELECT
  • NM_001079803.3:c.309C>G
  • NM_001079804.3:c.309C>G
  • NP_000143.2:p.Cys103Trp
  • NP_001073271.1:p.Cys103Trp
  • NP_001073272.1:p.Cys103Trp
  • LRG_673:g.8340C>G
  • NC_000017.10:g.78078694C>G
Protein change:
C103W
Links:
dbSNP: rs373307393
NCBI 1000 Genomes Browser:
rs373307393
Molecular consequence:
  • NM_000152.5:c.309C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079803.3:c.309C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079804.3:c.309C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Glycogen storage disease, type II (GSD2)
Synonyms:
ACID ALPHA-GLUCOSIDASE DEFICIENCY; GLYCOGENOSIS, GENERALIZED, CARDIAC FORM; GSD II; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009290; MedGen: C0017921; Orphanet: 365; OMIM: 232300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002175424Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 29, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.

Hermans MM, van Leenen D, Kroos MA, Beesley CE, Van Der Ploeg AT, Sakuraba H, Wevers R, Kleijer W, Michelakakis H, Kirk EP, Fletcher J, Bosshard N, Basel-Vanagaite L, Besley G, Reuser AJ.

Hum Mutat. 2004 Jan;23(1):47-56.

PubMed [citation]
PMID:
14695532

Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease.

Pittis MG, Donnarumma M, Montalvo AL, Dominissini S, Kroos M, Rosano C, Stroppiano M, Bianco MG, Donati MA, Parenti G, D'Amico A, Ciana G, Di Rocco M, Reuser A, Bembi B, Filocamo M.

Hum Mutat. 2008 Jun;29(6):E27-36. doi: 10.1002/humu.20753.

PubMed [citation]
PMID:
18429042
See all PubMed Citations (8)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002175424.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change replaces cysteine, which is neutral and slightly polar, with tryptophan, which is neutral and slightly polar, at codon 103 of the GAA protein (p.Cys103Trp). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys103 amino acid residue in GAA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14695532, 18429042, 18607768, 21109266, 24158270, 29181627). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GAA protein function. ClinVar contains an entry for this variant (Variation ID: 1400946). This missense change has been observed in individual(s) with Pompe disease (PMID: 27142047). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (no rsID available, gnomAD 0.003%).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024